We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Alphabet, Walmart, Micron Technology and NeurAxis
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 5, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alphabet Inc. (GOOGL - Free Report) , Walmart Inc. (WMT - Free Report) , Micron Technology, Inc. (MU - Free Report) and NeurAxis, Inc. (NRXS - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Stock Reports for Alphabet, Walmart & Micron
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc., Walmart Inc. and Micron Technology, Inc., as well as a micro-cap stock NeurAxis, Inc. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.
Alphabet’s shares have outperformed the Zacks Internet - Services industry over the past six months (+34.4% vs. +30.9%). The company’s AI-led product cycle continues to support growth across Search, Cloud and subscriptions. Search is benefitting from AI Overviews and AI Mode, which are driving higher usage and enabling new ad formats such as AI Max and direct offers in AI Mode.
Google Cloud is scaling faster as enterprises adopt AI infrastructure and AI solutions, and rising backlog provides better revenue visibility over the next two years. Paid subscriptions across Google One and YouTube keep expanding, supporting a more diversified revenue mix, while Waymo’s ride volumes point to steady progress in Other Bets.
Alphabet retains ample liquidity, but higher debt and elevated capital spending needs limit near-term flexibility and can create volatility in free cash flow. Overall, execution gains are balanced by spending, competition and legal risk.
Shares of Walmart have outperformed the Zacks Retail - Supermarkets industry over the past six months (+30.1% vs. +28.8%). The company continues to strengthen its position as a leading omnichannel retailer, supported by its scale, price leadership and expanding digital ecosystem. Walmart is benefiting from consistent traffic gains, resilient demand and increasing contributions from higher-margin businesses such as advertising and membership.
The company's integrated store and e-commerce model enables faster fulfillment, while ongoing investments in automation and technology are improving efficiency. Disciplined inventory management and a growing marketplace platform are also supporting better working capital and profitability.
While Walmart remains well placed to drive steady sales and earnings growth, margin expansion could remain gradual due to continued investments, mix shifts toward essentials and external factors such as tariffs and macroeconomic uncertainty.
Micron’s shares have outperformed the Zacks Computer - Integrated Systems industry over the past six months (+146.1% vs. +41%). The company is benefiting from the rapidly expanding artificial intelligence (AI)-driven memory and storage markets. The positive impacts of inventory improvement across multiple end markets are driving top-line growth.
The surging demand for HBM and robust DRAM pricing recovery will aid significant revenue and earnings growth in the coming quarters. Its solid financials, positive free cash flow and strong balance sheet provide the flexibility to invest in growth initiatives while enhancing shareholder value.
Micron’s long-term customer agreements and expanding AI partnerships reduce volatility and enhance revenue visibility. Nonetheless, rising operating costs and a massive increase in capital expenditure pose a downside risk to Micron’s near-term profitability.
Shares of NeurAxis have outperformed the Zacks Medical Info Systems industry over the past six months (+219.7% vs. -34.9%). This microcap company with a market capitalization of $92.96 million targets a large, underserved gut-brain disorder market with a differentiated, non-pharmacologic neuromodulation therapy supported by clinical validation and guideline inclusion.
The investment thesis centers on expanding payer coverage, improving reimbursement infrastructure, and a scalable, payer-focused commercialization model that can drive broader adoption across pediatric and adult populations. Early revenue growth and high-margin potential reflect operating leverage as utilization increases, while pipeline expansion and new products add optionality.
However, the story remains execution-driven, with risks tied to reimbursement consistency, adoption pace and ongoing capital needs. Continued losses and dilution risk highlight reliance on external funding. The valuation implies strong adoption and scaling, leaving limited margin for missteps.
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
The Zacks Analyst Blog Highlights Alphabet, Walmart, Micron Technology and NeurAxis
For Immediate Release
Chicago, IL – May 5, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alphabet Inc. (GOOGL - Free Report) , Walmart Inc. (WMT - Free Report) , Micron Technology, Inc. (MU - Free Report) and NeurAxis, Inc. (NRXS - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Stock Reports for Alphabet, Walmart & Micron
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc., Walmart Inc. and Micron Technology, Inc., as well as a micro-cap stock NeurAxis, Inc. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Ahead of Wall Street
The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.
You can read today's AWS here >>> Pre-Markets Mixed to Begin New Trading Week
Today's Featured Research Reports
Alphabet’s shares have outperformed the Zacks Internet - Services industry over the past six months (+34.4% vs. +30.9%). The company’s AI-led product cycle continues to support growth across Search, Cloud and subscriptions. Search is benefitting from AI Overviews and AI Mode, which are driving higher usage and enabling new ad formats such as AI Max and direct offers in AI Mode.
Google Cloud is scaling faster as enterprises adopt AI infrastructure and AI solutions, and rising backlog provides better revenue visibility over the next two years. Paid subscriptions across Google One and YouTube keep expanding, supporting a more diversified revenue mix, while Waymo’s ride volumes point to steady progress in Other Bets.
Alphabet retains ample liquidity, but higher debt and elevated capital spending needs limit near-term flexibility and can create volatility in free cash flow. Overall, execution gains are balanced by spending, competition and legal risk.
(You can read the full research report on Alphabet here >>>)
Shares of Walmart have outperformed the Zacks Retail - Supermarkets industry over the past six months (+30.1% vs. +28.8%). The company continues to strengthen its position as a leading omnichannel retailer, supported by its scale, price leadership and expanding digital ecosystem. Walmart is benefiting from consistent traffic gains, resilient demand and increasing contributions from higher-margin businesses such as advertising and membership.
The company's integrated store and e-commerce model enables faster fulfillment, while ongoing investments in automation and technology are improving efficiency. Disciplined inventory management and a growing marketplace platform are also supporting better working capital and profitability.
While Walmart remains well placed to drive steady sales and earnings growth, margin expansion could remain gradual due to continued investments, mix shifts toward essentials and external factors such as tariffs and macroeconomic uncertainty.
(You can read the full research report on Walmart here >>>)
Micron’s shares have outperformed the Zacks Computer - Integrated Systems industry over the past six months (+146.1% vs. +41%). The company is benefiting from the rapidly expanding artificial intelligence (AI)-driven memory and storage markets. The positive impacts of inventory improvement across multiple end markets are driving top-line growth.
The surging demand for HBM and robust DRAM pricing recovery will aid significant revenue and earnings growth in the coming quarters. Its solid financials, positive free cash flow and strong balance sheet provide the flexibility to invest in growth initiatives while enhancing shareholder value.
Micron’s long-term customer agreements and expanding AI partnerships reduce volatility and enhance revenue visibility. Nonetheless, rising operating costs and a massive increase in capital expenditure pose a downside risk to Micron’s near-term profitability.
(You can read the full research report on Micron here >>>)
Shares of NeurAxis have outperformed the Zacks Medical Info Systems industry over the past six months (+219.7% vs. -34.9%). This microcap company with a market capitalization of $92.96 million targets a large, underserved gut-brain disorder market with a differentiated, non-pharmacologic neuromodulation therapy supported by clinical validation and guideline inclusion.
The investment thesis centers on expanding payer coverage, improving reimbursement infrastructure, and a scalable, payer-focused commercialization model that can drive broader adoption across pediatric and adult populations. Early revenue growth and high-margin potential reflect operating leverage as utilization increases, while pipeline expansion and new products add optionality.
However, the story remains execution-driven, with risks tied to reimbursement consistency, adoption pace and ongoing capital needs. Continued losses and dilution risk highlight reliance on external funding. The valuation implies strong adoption and scaling, leaving limited margin for missteps.
(You can read the full research report on NeurAxis here >>>)
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.